PA Biotech Center just announced a $50M investment fund and accelerator - Philly


Jul. 25, 2019 7:12 am

PA Biotech Center just announced a $50M investment fund and accelerator

The Doylestown-based life sciences incubator announced it's also adding a new building to the campus for the accelerator, with expected completion in 2020.

Pennsylvania Biotech Center's future expanded campus.

(Courtesy image)

The Pennsylvanian Biotech Center is launching a $50 million dollar investment fund and accelerator for early-stage companies, the nonprofit life sciences incubator announced Wednesday.

Hatch BioFund Management, LLC, the overarching organization for the new initiatives, will be headed by financial services firm Janney Montgomery Scott’s former managing director in healthcare investment banking, Vladimir Walko.

While the fund will primarily fund seed stage and Series A rounds for incubator companies the center is already familiar with, the Hatch BioAccelerator Program will focus on pre-incubator companies for the center to follow from early-stage investment to market. The accelerator will offer young companies seed capital, lab space, business creation services and guidance, and other resources.

“We really focus on collaboration,” PA Biotech Center COO Louis Kassa said. “We can work together, cross-pollinate and from that help [companies] with their success, expediting whatever science they’re trying to achieve.”

The center, which was voted one of the most successful life science centers in the U.S. last year by the International Business Innovation Association, created the fund as a way to generate more revenue for its research while helping local companies. The fund will be available to both current companies working in the center’s incubator, as well as four to five pre-incubation companies in the accelerator program.

Kassa said the new program is available for both the one- to two-person companies the center incubates as well as larger operations.

“One of our ingredients is that we don’t kick companies out, because senior companies help our ecosystem stay strong,” Kassa said.

The COO said the Biotech Center’s location is key to its success: Based in the heart of the “Pharma Belt” — between New Jersey and Philadelphia — the Doylestown campus offers close access to nine local universities and is within 100 miles of 70% of all pharmaceutical companies, according to Kassa. The nonprofit is also adding a new building to the campus for the accelerator, with expected completion in 2020.


“I think that we have a tremendous opportunity to be one of the biotech hubs of the country,” Kassa said. “I think Philadelphia definitely has the talent.”

Already a member? Sign in here
Connect with companies from the community
New call-to-action


Why this Radnor-based VC firm thinks impact investing is on the rise

Brookings report: ‘Pennsylvania’s innovation economy has gone flat’

Philly startups need more early-stage investments to compete



Meet these 10 hiring companies at Super Meetup



UX Designer

Apply Now
Chesterbrook, PA


Inside Sales Representative

Apply Now
Horsham, PA

Penn Mutual

Product Owner/Business Transformation Specialist

Apply Now

Here’s how much venture capital Philly companies have raised so far in 2019

Philly Startup Leaders just launched a new website and plans for a resource center

Fox’s Innovation and Entrepreneurship Institute launches 1810 Accelerator for homegrown startups



Verizon is looking for the brightest ideas on how to use its 5G technology

Center City


Member Experience Specialist

Apply Now
Philadelphia, PA


Frontend Engineer

Apply Now

Sign-up for daily news updates from Philadelphia

Do NOT follow this link or you will be banned from the site!